Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2015
Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation
Pierre Bohanes, Cathryn J Rankin, Charles D Blanke, et al.
Wiener Klinische Wochenschrift
|
February 16, 2022
SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide study
Julia M Berger, Phillipp Wohlfarth, Oliver Königsbrügge, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 2024
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data
Patrick Reimann, Ilektra-Antonia Mavroeidi, Jonathan Burghofer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2018
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
Pratiksha Gulati, Julia Rühl, Abhilash Kannan, et al.
Annals of Hematology
|
March 4, 2024
Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies
Patrick Reimann, Verena Petzer, Axel Mündlein, et al.
Therapeutic Advances in Medical Oncology
|
April 22, 2020
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Austrian multicenter, noninterventional study
Jakob Michael Riedl, Florian Posch, Gerald Prager, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 9, 2020
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study
Gerald W Prager, Leopold Oehler, Armin Gerger, et al.
Journal for Immunotherapy of Cancer
|
December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study
Dominik A Barth, Florian Moik, Sarah Steinlechner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2025
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study
Sebastian Stintzing, Susanne Klein-Scory, Ludwig Fischer von Weikersthal, et al.
The New England Journal of Medicine
|
October 23, 2023
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
John V Heymach, David Harpole, Tetsuya Mitsudomi, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2015
Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation
Pierre Bohanes, Cathryn J Rankin, Charles D Blanke, et al.
Wiener Klinische Wochenschrift
|
February 16, 2022
SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide study
Julia M Berger, Phillipp Wohlfarth, Oliver Königsbrügge, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 2024
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data
Patrick Reimann, Ilektra-Antonia Mavroeidi, Jonathan Burghofer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2018
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
Pratiksha Gulati, Julia Rühl, Abhilash Kannan, et al.
Annals of Hematology
|
March 4, 2024
Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies
Patrick Reimann, Verena Petzer, Axel Mündlein, et al.
Therapeutic Advances in Medical Oncology
|
April 22, 2020
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Austrian multicenter, noninterventional study
Jakob Michael Riedl, Florian Posch, Gerald Prager, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 9, 2020
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study
Gerald W Prager, Leopold Oehler, Armin Gerger, et al.
Journal for Immunotherapy of Cancer
|
December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study
Dominik A Barth, Florian Moik, Sarah Steinlechner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2025
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study
Sebastian Stintzing, Susanne Klein-Scory, Ludwig Fischer von Weikersthal, et al.
The New England Journal of Medicine
|
October 23, 2023
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
John V Heymach, David Harpole, Tetsuya Mitsudomi, et al.
Page
of 10